OPTINOSE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.06 USD | +1.92% |
|
-1.85% | -17.83% |
| 05-20 | OptiNose, Inc. announced that it has received $4.68 million in funding | CI |
| 05-14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 154M | - | - | - | |||
| 765B | ||||||
| 632B | ||||||
| 354B | ||||||
| 331B | ||||||
| 299B |
- Stock Market
- Equities
- OPTN Stock
- Charts OptiNose, Inc.
- Sector Chart
